Non-conventional dysplastic subtypes in inflammatory bowel disease: a review of their diagnostic characteristics and potential clinical implications

키워드

참고문헌 (58)

1. Ekbom A, "Ulcerative colitis and colorectal cancer : a population-based study", N Engl J Med, 323, pp.1228~1233 (1990)
2. Soderlund S, "Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease", Gastroenterology, 136, pp.1561~1567 (2009)
3. Bernstein CN, "Cancer risk in patients with inflammatory bowel disease : a population-based study", Cancer, 91, pp.854~862 (2001)
4. Jess T, "Risk of colorectal cancer in patients with ulcerative colitis : a meta-analysis of population-based cohort studies", Clin Gastroenterol Hepatol, 10, pp.639~645 (2012)
5. Ekbom A, "Increased risk of largebowel cancer in Crohn's disease with colonic involvement", Lancet, 336, pp.357~359 (1990)
6. Eaden JA, "The risk of colorectal cancer in ulcerative colitis : a meta-analysis", Gut, 48, pp.526~535 (2001)
7. Soetikno RM, "Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis : a meta-analysis", Gastrointest Endosc, 56, pp.48~54 (2002)
8. Beaugerie L, "Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease", Gastroenterology, 145, pp.166~175 (2013)
9. Lutgens MW, "Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease", Br J Cancer, 101, pp.1671~1675 (2009)
10. Karlen P, "Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study", Gut, 42, pp.711~714 (1998)
11. Eaden J, "Colorectal cancer prevention in ulcerative colitis : a case-control study", Aliment Pharmacol Ther, 14, pp.145~153 (2000)
12. Choi CH, "Forty-year analysis of colonoscopic surveillance program for neoplasia in ulcerative colitis : an updated overview", Am J Gastroenterol, 110, pp.1022~1034 (2015)
13. Laine L, "SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease", Gastrointest Endosc, 81, pp.489~501 (2015)
14. Farraye FA, "AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease", Gastroenterology, 138, pp.738~745 (2010)
15. Leighton JA, "ASGE guideline : endoscopy in the diagnosis and treatment of inflammatory bowel disease", Gastrointest Endosc, 63, pp.558~565 (2006)
16. Odze RD, "Adenomas and adenoma-like DALMs in chronic ulcerative colitis : a clinical, pathological, and molecular review", Am J Gastroenterol, 94, pp.1746~1750 (1999)
17. Rutter MD, "Most dysplasia in ulcerative colitis is visible at colonoscopy", Gastrointest Endosc, 60, pp.334~339 (2004)
18. Rubin DT, "Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?", Gastrointest Endosc, 65, pp.998~1004 (2007)
19. Wanders LK, "Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis : a meta-analysis", Clin Gastroenterol Hepatol, 12, pp.756~764 (2014)
20. Blonski W, "High-grade dysplastic adenoma-like mass lesions are not an indication for colectomy in patients with ulcerative colitis", Scand J Gastroenterol, 43, pp.817~820 (2008)
21. Odze RD, "Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis", Clin Gastroenterol Hepatol, 2, pp.534~541 (2004)
22. Kisiel JB, "Outcome of sporadic adenomas and adenoma-like dysplasia in patients with ulcerative colitis undergoing polypectomy", Inflamm Bowel Dis, 18, pp.226~235 (2012)
23. Connell WR, "Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis", Gastroenterology, 107, pp.934~944 (1994)
24. Friedman S, "Screening and surveillance colonoscopy in chronic Crohn's colitis", Gastroenterology, 120, pp.820~826 (2001)
25. Hata K, "Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer : results of a 23-year surveillance programme in the Japanese population", Br J Cancer, 89, pp.1232~1236 (2003)
26. Bernstein CN, "Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?", Lancet, 343, pp.71~74 (1994)
27. Thomas T, "Meta-analysis : cancer risk of low-grade dysplasia in chronic ulcerative colitis", Aliment Pharmacol Ther, 25, pp.657~668 (2007)
28. Jess T, "Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease : a populationbased study from Olmsted County, Minnesota", Inflamm Bowel Dis, 12, pp.669~676 (2006)
29. Ullman T, "Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis", Gastroenterology, 125, pp.1311~1319 (2003)
30. Ullman TA, "The fate of low grade dysplasia in ulcerative colitis", Am J Gastroenterol, 97, pp.922~927 (2002)
31. van Schaik FD, "Misclassification of dysplasia in patients with inflammatory bowel disease : consequences for progression rates to advanced neoplasia", Inflamm Bowel Dis, 17, pp.1108~1116 (2011)
32. Befrits R, "Low-grade dysplasia in extensive, long-standing inflammatory bowel disease : a follow-up study", Dis Colon Rectum, 45, pp.615~620 (2002)
33. Venkatesh PG, "Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis", J Crohns Colitis, 7, pp.968~973 (2013)
34. Pekow JR, "Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis", Inflamm Bowel Dis, 16, pp.1352~1356 (2010)
35. Zisman TL, "Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines", Inflamm Bowel Dis, 18, pp.2240~2246 (2012)
36. Navaneethan U, "Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance", J Crohns Colitis, 7, pp.e684~e691 (2013)
37. Tsai JH, "Association of aneuploidy and flat dysplasia with development of high-grade dysplasia or colorectal cancer in patients with inflammatory bowel disease", Gastroenterology, 153, pp.1492~1495 (2017)
38. Hannah Lee, "Non‐conventional dysplasia in inflammatory bowel disease is more frequently associated with advanced neoplasia and aneuploidy than conventional dysplasia", Histopathology, 78(6), pp.814~830 (2021), Wiley[DOI]
39. Wanders LK, "IBD-associated dysplastic lesions show more chromosomal instability than sporadic adenomas", Inflamm Bowel Dis, 26, pp.167~180 (2020)
40. Riddell RH, "Dysplasia in inflammatory bowel disease : standardized classification with provisional clinical applications", Hum Pathol, 14, pp.931~968 (1983)
41. Choi WT, "Nonconventional dysplasia in patients with inflammatory bowel disease and colorectal carcinoma : a multicenter clinicopathologic study", Mod Pathol, 33, pp.933~943 (2020)
42. Wen KW, "DNA flow cytometric and interobserver study of crypt cell atypia in inflammatory bowel disease", Histopathology, 75, pp.578~588 (2019)
43. Daniela Pereira, "Non‐conventional dysplasias of the tubular gut: a review and illustration of their histomorphological spectrum", Histopathology, 78(5), pp.658~675 (2021), Wiley[DOI]
44. Watanabe T, "Comparison of targeted vs random biopsies for surveillance of ulcerative colitis-associated colorectal cancer", Gastroenterology, 151, pp.1122~1130 (2016)
45. Andersen SN, "Villous, hypermucinous mucosa in long standing ulcerative colitis shows high frequency of K-ras mutations", Gut, 45, pp.686~692 (1999)
46. Maltzman T, "Ki-ras proto-oncogene mutations in sporadic colorectal adenomas : relationship to histologic and clinical characteristics", Gastroenterology, 121, pp.302~309 (2001)
47. Gui X, "Histological and molecular diversity and heterogeneity of precancerous lesions associated with inflammatory bowel diseases", J Clin Pathol, 73, pp.391~402 (2020)
48. Vogelstein B, "Genetic alterations during colorectal-tumor development", N Engl J Med, 319, pp.525~532 (1988)
49. Ried T, "Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors", Genes Chromosomes Cancer, 15, pp.234~245 (1996)
50. Meijer GA, "Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation", J Clin Pathol, 51, pp.901~909 (1998)
51. Lomo LC, "Crypt dysplasia with surface maturation : a clinical, pathologic, and molecular study of a Barrett’s esophagus cohort", Am J Surg Pathol, 30, pp.423~435 (2006)
52. Joo M, "Paneth cell differentiation in colonic epithelial neoplasms : evidence for the role of the Apc", beta-catenin, Hum Pathol, pp.2009, 40[DOI]
53. Mahon M, "Paneth cell in adenomas of the distal colorectum is inversely associated with synchronous advanced adenoma and carcinoma", Sci Rep, 6, pp.26129~ (2016)
54. Bansal M, "Are metaplasias in colorectal adenomas truly metaplasias?", Am J Pathol, 115, pp.253~265 (1984)
55. Pai RK, "Paneth cells in colonic adenomas : association with male sex and adenoma burden", Am J Surg Pathol, 37, pp.98~103 (2013)
56. Ko HM, "Serrated colorectal polyps in inflammatory bowel disease", Mod Pathol, 28, pp.1584~1593 (2015)
57. Yang C, "Clinical, histologic, and immunophenotypic features of serrated polyps in patients with inflammatory bowel disease", Gastroenterology Res, 11, pp.355~360 (2018)
58. Choi WT, "DNA content analysis of colorectal serrated lesions detects an aneuploid subset of inflammatory bowel disease-associated serrated epithelial change and traditional serrated adenomas", Histopathology, 73, pp.464~472 (2018)

관련 논문AI추천